FDA allows Zyn pouches to be marketed as less harmful than cigarettes
Key takeaways
- The agency allowed the company to market 10 flavors of Zyn products, which have been authorized for sale in the U.S. since January 2025.
- It s a significant win for tobacco giant Philip Morris International and comes as the Trump administration loosens restrictions on nicotine products.
- The flavors include Zyn Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint and Wintergreen, each in 3-milligram and 6-milligram nicotine strengths.
Why this matters: political developments that affect policy direction and public trust.
The agency allowed the company to market 10 flavors of Zyn products, which have been authorized for sale in the U.S. since January 2025. These are the first nicotine pouches that are allowed to be marketed with a modified risk claim.
It s a significant win for tobacco giant Philip Morris International and comes as the Trump administration loosens restrictions on nicotine products. The pouches are produced and marketed by Swedish Match, a Stockholm-based tobacco company owned by PMI.
The FDA will allow the 10 Zyn flavors in two different nicotine strengths to be marketed with the claim that using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.